News on Medial

Related News

PB Healthcare to raise Rs 1,461 Cr in seed round; no longer subsidiary of PB Fintech

EntrackrEntrackr · 2m ago
PB Healthcare to raise Rs 1,461 Cr in seed round; no longer subsidiary of PB Fintech
Medial

PB Healthcare Services, formerly a wholly-owned subsidiary of PB Fintech Limited, is raising Rs 1,461 crore (approximately $171 million) as part of the first tranche of its seed round. Of the total amount, Rs 539.4 crore has already been infused by PB Fintech Limited, while the remaining capital will be contributed by external investors, according to disclosures filed with the National Stock Exchange (NSE). For context, PB Fintech had earlier passed a resolution to invest up to Rs 696 crore through the purchase of equity shares or preference shares of PB Healthcare Services Private Limited in FY26. As part of the current round, it has already invested Rs 539.4 crore, with the remaining amount yet to be deployed. As per the filings, PB Fintech’s stake in PB Healthcare Services has dropped from 100% to 32.14% following the participation of external investors in the seed round. Previously a wholly-owned subsidiary, PB Healthcare has also created an ESOP pool to attract and retain key talent. The capital infusion is aimed at strengthening the company’s financial position and supporting its growth plans. “The dilution in shareholding is a strategic decision to bring in external investors and create an ESOP pool to attract and retain talent,” the company noted in its filing. Founded in January 2025, PB Healthcare Services set out with an ambitious goal of establishing hospitals with a cumulative capacity of 1,000 beds within its first year. The company plans to launch operations in the National Capital Region (NCR), with a phased expansion into other major metro cities.

HealthKois launches $300 Mn healthcare transformation fund

EntrackrEntrackr · 1m ago
HealthKois launches $300 Mn healthcare transformation fund
Medial

HealthKois launches $300 Mn healthcare transformation fund Healthcare-focused investment firm HealthKois has launched with a target corpus of $300 million, along with a $100 million green shoe option. Spearheaded by the founding team behind HealthQuad — Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr. Pinak Shrikhande (Partner) — HealthKois will back early growth-stage healthcare companies across healthtech, life sciences, medtech, healthcare delivery, and climate health. The fund plans to invest between $7 million to $25 million per company over the next four years, focusing on businesses with proven clinical outcomes, scalable operations, and sustainable infrastructure models. “HealthKois will support healthcare enterprises addressing gaps in access, affordability, and quality,” said Charles Janssen. “With access to over 75% proprietary deal flow, we are positioned to deliver both financial returns and real-world health impact.” HealthKois will adopt a hands-on, founder-first approach, offering capital alongside strategic guidance, market expansion support, and governance planning. The firm’s team brings over 100 years of combined experience in clinical care, operations, and healthcare investing, and operates across Asia and Europe. HealthKois builds on the success of HealthQuad Funds I and II, which claims to have impacted over 90 million lives and serve more than 8 million patients annually.

Download the medial app to read full posts, comements and news.